Quality Chemical Industries Limited, a pharmaceutical manufacturing company, produces treatments for HIV/AIDS, Malaria, Hepatitis, and other products in Uganda. It offers antibacterials, anti-hypertensives, vasodilators, anti-emetics, antibiotics, and antidiabetics products; and Lamivudine/Tenofovir Disoproxil Fumarate, Dolutegravir, Efavirenz, and Zidovudine tablets for the treatment of HIV infection. The company also offers Lumartem/Lumet tablets for the treatment of malaria; Texavir and Zentair for the treatment of Hepatitis B; and Isoniazid/Pyridoxine Hydrochloride /Sulfamethoxazole Trimethoprim tablets for the treatment of tuberculosis. In addition, it provides Emeset for the treatment of nausea and vomiting; Ciplox and Azicip, anti-infectives to prevent and treat infections; Amlopres to treat hypertension; and Erecto for the treatment of reproductive disorders, such as erectile dysfunction. It also exports its products to approximately 13 countries in Africa. The company was formerly known as Cipla Quality Chemical Industries Limited and changed its name to Quality Chemical Industries Limited in February 2024. The company was incorporated in 2005 and is based in Kampala, Uganda. Quality Chemical Industries Limited is a subsidiary of Cipla Limited.
Metrics to compare | CQCIL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCQCILPeersSector | |
---|---|---|---|---|
P/E Ratio | 6.3x | 18.7x | −0.6x | |
PEG Ratio | 0.09 | 0.17 | 0.00 | |
Price/Book | - | 1.9x | 2.6x | |
Price / LTM Sales | 0.8x | 2.5x | 3.2x | |
Upside (Analyst Target) | - | 23.6% | 48.6% | |
Fair Value Upside | Unlock | 12.7% | 7.0% | Unlock |